Prof Paul Griffiths

Photo

Personal Profile

Name: Paul Griffiths Email: p.griffiths@ucl.ac.uk
Title: Prof Tel: 020 7830 2997
Department: Div of Infection & Immunity Fax: 020 7830 2854
Position: Professor of Virology Address: Centre for Virology, UCL Medical School, Rowland Hill Street, London, NW3 2PF
Research Domain: Experimental Medicine, Global Health, Infection, Immunology & Inflammation, Personalised Medicine Web Page: Personal Web Page

Profile

Research Description

My research concerns quantitative aspects of the natural history and pathogenesis of herpesvirus infections, especially cytomegalovirus in immunocompromised renal, liver and bone marrow transplant patients, in addition to the potential interaction between herpesviruses and HIV. My interests are in the design of, and results from controlled clinical trials of compounds or vaccines active against herpesviruses, which when used as probes of pathogenesis may reveal the full spectrum of diseases caused or triggered by these common infectious agents.

My group has recently completed a Phase II trial into a novel vaccine for cytomegalovirus with positive results.I am now in the process of investigating further and alternate vaccine trials for cytomegalovirus.

Research Activities

CMV Pathogenesis and Development of Vaccines

Gene and Cellular Therapy of Haematological Malignancies

Molecular mechanisms of viral immunomodulation and immunosuppression

Education Description

MBBS, Intercalated BSc, Viva Voce

UCL Collaborators

Prof Hans Stauss; Prof Adrian Thrasher; Prof Richard Tedder; Prof Arne Akbar; Dr Karl Peggs; Prof Samuel Janes; Dr Richard Milne; Prof Caroline Sabin; Prof Deenan Pillay; Dr Emma Morris

External Collaborators

Publications

    2014

    • Griffiths PD (2014). Of London buses and the treatment of cytomegalovirus infection.. Rev Med Virol, 24(4), 221 - 222. doi:10.1002/rmv.1800
    • Lumley S, Patel M, Griffiths PD (2014). The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.. J Med Virol, , - . doi:10.1002/jmv.23863
    • Griffiths PD, Emery VC (2014). Taming the transplantation troll by targeting terminase. New England Journal of Medicine, 370(19), 1844 - 1846. doi:10.1056/NEJMe1401567

    2012

    • Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD (2012). Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.. Am J Transplant, 12(9), 2457 - 2464. doi:10.1111/j.1600-6143.2012.04087.x
    • Griffiths PD (2012). Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. The Lancet Infectious Diseases, 12(10), 790 - 798. doi:10.1016/S1473-3099(12)70197-4
    • Halliday N, Wilmore S, Griffiths PD, Neuberger J, Thorburn D (2012). Risk of transmission of H1N1 influenza by solid organ transplantation in the United Kingdom.. Transplantation, 93(5), 551 - 554. doi:10.1097/TP.0b013e3182445e71

    2011

    • Luck S, Lovering A, Griffiths P, Sharland M (2011). Ganciclovir treatment in children: evidence of subtherapeutic levels.. Int J Antimicrob Agents, 37(5), 445 - 448. doi:10.1016/j.ijantimicag.2010.11.033
    • Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK (2011). Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.. Lancet, 377(9773), 1256 - 1263. doi:10.1016/S0140-6736(11)60136-0

    2010

    • Carpenter BJM, Dimopoulou M, Grace S, Denovan S, Orti G, Atkinson C, Roughton M, Hague T, Griffiths P, Fielding A, Kottaridis P, Mackinnon S, Chakraverty R (2010). In vivo Campath-1h is associated with a high incidence of EBV viraemia but low risk of PTLD following allogeneic stem cell transplantation.
    • Luck S, Griffiths PD, Sharland M (2010). Response to Gandhi et al., Management of congenital cytomegalovirus infection. ACTA PAEDIATR, 99(10), 1445 - 1445. doi:10.1111/j.1651-2227.2010.01840.x
    • Buyck HC, Griffiths PD, Emery VC (2010). Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy.. J Clin Virol, 49(1), 32 - 36. doi:10.1016/j.jcv.2010.06.018
    • Buyck HC, Prentice HG, Griffiths PD, Emery VC (2010). The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients.. Bone Marrow Transplant, 45(7), 1212 - 1219. doi:10.1038/bmt.2009.329
    • Kopycinski J, Osman M, Griffiths PD, Emery VC (2010). Sequence flexibility of the immunodominant HLA A*0201 restricted ppUL83 CD8 T-cell epitope of human cytomegalovirus.. J Med Virol, 82(1), 94 - 103. doi:10.1002/jmv.21668
    • Li YT, Emery VC, Surah S, Jarmulowicz M, Sweny P, Kidd IM, Griffiths PD, Clark DA (2010). Extensive Human Cytomegalovirus (HCMV) Genomic DNA in the Renal Tubular Epithelium Early After Renal Transplantation: Relationship With HCMV DNAemia and Long-Term Graft Function. J MED VIROL, 82(1), 85 - 93. doi:10.1002/jmv.21662
    • Carpenter B, Haque T, Dimopoulou M, Atkinson C, Roughton M, Grace S, Denovan S, Fielding A, Kottaridis PD, Griffiths P, Mackinnon S, Emery V, Chakraverty R (2010). Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation.. Transplantation, 90(5), 564 - 570. doi:10.1097/TP.0b013e3181e7a3bf

    2009

    • Nibali L, Atkinson C, Griffiths P, Darbar UR, Rakmanee T, Suvan JE, Donos N (2009). Low prevalence of subgingival viruses in periodontitis patients. Journal of Clinical Periodontology, 36(11), 928 - 932.
    • Griffiths PD (2009). CMV vaccine trial endpoints.. J Clin Virol, 46 Suppl 4, S64 - S67. doi:10.1016/j.jcv.2009.10.003
    • Harrison TJ, Dusheiko GMZ, A J (2009). Hepatitis Viruses. In Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, Mortimer P (Ed.), Principles and Practice of Clinical Virology (pp. 273 - 320). : John Wiley & Sons, Ltd.
    • Atkinson C, Walter S, Sharland M, Tookey P, Luck S, Peckham C, Griffithsi P (2009). Use of Stored Dried Blood Spots for Retrospective Diagnosis of Congenital CMV. Journal of Medical Virology, 81(8), 1394 - 1398.
    • Griffiths PD (2009). A perspective on antiviral resistance. J CLIN VIROL, 46(1), 3 - 8. doi:10.1016/j.jcv.2009.06.017

    2008

    • Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD (2008). Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Archives of Disease in Childhood - Fetal and Neonatal Edition, 93, F280 - F285. doi:10.1136/adc.2007.119230
    • Nebbia G, Mattes FM, Smith C, Hainsworth E, Kopycinski J, Burroughs A, Griffiths PD, Klenerman P, Emery VC (2008). Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. American Journal of Transplantation, 8(12), 2590 - 2599. doi:10.1111/j.1600-6143.2008.02425.x
    • Mattes FM, Vargas A, Kopycinski J, Hainsworth EG, Sweny P, Nebbia G, Bazeos A, Lowdell M, Klenerman P, Phillips RE, Griffiths PD, Emery VC (2008). Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. American Journal of Transplantation, 8(5), 990 - 999. doi:10.1111/j.1600-6143.2008.02191.x
    • Griffiths P, Whitley R, Snydman DR, Singh N, Boeckh M, International Herpes Management Forum (2008). Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.. Herpes, 15(1), 4 - 12.
    • Griffiths PD (2008). Viruses in the era of global warming. Reviews in Medical Virology, 18(2), 69 - 71. doi:10.1002/rmv.572

    2007

    • Luck S, Sharland M, Griffiths P (2007). Ganciclovir therapy for neonates with congenital cytomegalovirus infection. EUR J PEDIATR, 166(6), 633 - 634. doi:10.1007/s00431-006-0288-8
    • Johnson RW, Griffiths P (2007). Global strategies to prevent herpes zoster and its associated complications. Herpes, 14(SUPPL. 2), - .
    • Leong HN, Tuke PW, Tedder RS, Khanom AB, Eglin RP, Atkinson CE, Ward KN, Griffiths PD, Clark DA (2007). The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. Journal of Medical Virology, 79(1), 45 - 51.

    2006

    • Griffiths PD (2006). Happy anniversary for human cytomegalovirus. REV MED VIROL, 16(6), 349 - 352. doi:10.1002/rmv.523
    • Regoes RR, Bowen EF, Cope AV, Gor D, Hassan-Walker AF, Prentice HG, Johnson MA, Sweny P, Burroughs AK, Griffiths PD, Bonhoeffer S, Emery VC (2006). Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis. Proceedings of the Royal Society B: Biological Sciences, 273, 1961 - 1967. doi:10.1098/rspb.2006.3506
    • Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NWS, Griffiths P, Clark DA (2006). High level HHV-6 DNA and viral chromosomal integration.
    • Luck S, Sharland M, Griffiths P, Jenkins SM (2006). Advances in the antiviral therapy of herpes virus infection in children.. Expert Rev Anti Infect Ther, 4(6), 1005 - 1020. doi:10.1586/14787210.4.6.1005
    • Ward KN, Leong HN, Atkinson CE, Griffiths PD, Clark DA, Nacheva EP, Howard J, Davies NWS (2006). Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. Journal of Clinical Microbiology, 44(4), 1571 - 1574. doi:10.1128/JCM.44.4.1571-1574.2006
    • Griffiths PD (2006). Antivirals in the transplant setting. ANTIVIR RES, 71(2-3), 192 - 200. doi:10.1016/j.antiviral.2006.04.016
    • Griffiths PD (2006). CMV as a cofactor enhancing progression of AIDS.. J Clin Virol, 35(4), 489 - 492. doi:10.1016/j.jcv.2005.10.016
    • Clark DA, Nacheva EP, Leong HN, Brazma D, Li YT, Tsao EH, Buyck HC, Atkinson CE, Lawson HM, Potter MN, Griffiths PD (2006). Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.. J Infect Dis, 193(7), 912 - 916.
    • Griffiths P (2006). Herpes simplex virus and toll-like receptors. Herpes, 13(2), 31 - 31.
    • Nebbia G, Mattes FM, Ramaswamy M, Quaglia A, Verghese G, Griffiths PD, Burroughs A, Geretti AM (2006). Primary herpes simplex virus type-2 infection as a cause of liver failure after liver transplantation.. Transpl Infect Dis, 8(4), 229 - 232. doi:10.1111/j.1399-3062.2006.00144.x

    2005

    • Samonakis DN, Cholongitas E, Triantos CK, Griffiths P, Dhillon AP, Thalheimer U, Patch DW, Burroughs AK (2005). Sustained,spontaneous disapperance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis.. Journal of Hepatology, 43, 1091 - 1093.
    • Caplin B, Sweny P, Burroughs A, Emery V, Griffiths P (2005). Antiviral treatment after solid organ transplantation. LANCET, 366(9488), 806 - 807.
    • Caplin B, Sweny P, Burroughs A, Emery V, Griffiths P, Hodson EM, Webster AC, Strippoli GFM, Craig JC, Jones CA (2005). Antiviral treatment after solid organ transplantation [5] (multiple letters). Lancet, 366(9488), 806 - 807.
    • Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC (2005). Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir.. The Journal of Infectious Diseases, 191(1), 89 - 92.
    • Samonakis DN, Triantos CK, Thalheimer U, Quaglia A, Leandro G, Teixerira R, Papatheodoridis GV, Sabin CA, Rolando N, Davies S, Dhillon AP, Griffiths P, Emery V, Patch DW, Davidson BR, Rolles K, Burroughs AK (2005). Immunosuppression and dono age with respect to severity of HCV recurrence afte liver transplantation. Liver Transplantation, 17, 386 - 395.
    • Griffiths PD, Walter S (2005). Cytomegalovirus.. Curr Opin Infect Dis, 18(3), 241 - 245.

    2004

    • Hassan-Walker AF, Okwuadi S, Lee L, Griffiths PD, Emery VC (2004). Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus.. J Med Virol, 74(4), 573 - 579. doi:10.1002/jmv.20210
    • Tuke PW, Hawke S, Griffiths PD, Clark DA (2004). Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains. MULT SCLER, 10(4), 355 - 359. doi:10.1191/1352458504ms1057oa
    • Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ (2004). HSV-2 transmission.. Antiviral Research, 63(1), S27 - S35.
    • Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ (2004). HSV shedding.. Antiviral Research, 63(1), S19 - S26.
    • Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ (2004). Lessons from HIV and hepatitis viruses.. Antiviral Research, 63(1), S11 - S18.
    • Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ (2004). Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?. Antiviral Research, 63(1), S3 - S9.
    • Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ (2004). Is viral shedding a surrogate marker for transmission of genital herpes? Introduction. ANTIVIR RES, 63, S3 - S10. doi:10.1016/j.antiviral.2004.06.002
    • Khare M, Sharland M, Manyonda I, Rice P, Bland JM, Griffiths P (2004). Use of serial maternal urine cytomegalovirus PCR to detect primary CMV infection in seronegative pregnant women. J VIROL METHODS, 119(1), 31 - 35. doi:10.1016/j.vironmet.2004.02.013
    • Fryer JF, Griffiths PD, Emery VC, Clark DA (2004). Susceptibility of porcine cytomegalovirus to antiviral drugs.. J Antimicrob Chemother, 53(6), 975 - 980. doi:10.1093/jac/dkh231
    • Griffiths P (2004). Cytomegalovirus infection of the central nervous system.. Herpes, 11 Suppl 2, 95A - 104A.
    • Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GWG, Davison AJ (2004). Genetic content of wild-type human cytomegalovirus. J GEN VIROL, 85, 1301 - 1312. doi:10.1099/vir.0.79888-0
    • Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M, Burroughs AK, Sweny P, Hassan-Walker AF, Okwuadi S, Sabin C, Amooty G, Brown VS, Grace SC, Emery VC, Griffiths PD (2004). A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. The Journal of Infectious Diseases, 189(8), 1355 - 1361.
    • Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V (2004). Immune activation and CD8(+) T-cell differentiation towards senescence in HIV-1 infection. PLOS BIOL, 2(2), 173 - 185. doi:10.1371/journal.pbio.0020020
    • Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC (2004). Kinetics of CMV load reductions following pre-emptive therapy with valganciclovir or intravenous ganciclovir in adult solid organ transplant patients. American Journal of Transplantation, 4, 1373 - .
    • Deayton JR, Emery VC, Griffiths PD, Sabin CA, Johnson MA, Wilson P (2004). Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet, 363(9427), 2116 - 2121. doi:10.1016/S0140-6736(04)16500-8
    • Griffiths P (2004). Is viral shedding a surrogate marker for transmission of genital herpes? A discussion document.. Herpes, 11(3), 66 - 69.

    2003

    • Fryer J, Emery V, Griffiths P, Clark D (2003). Susceptibility of porcine cytomegalovirus to antiviral drugs.
    • Temperton NJ, Quenelle DC, Lawson KM, Zuckerman JN, Kern ER, Griffiths PD, Emery VC (2003). Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. Journal of Medical Virology, 70(1), 86 - 90. doi:10.1002/jmv.10357
    • Clark DA, Emery VC, Griffiths PD (2003). Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients.. Semin Hematol, 40(2), 154 - 162. doi:10.1053/shem.2003.50015
    • Clark DA, Fryer JF, Tucker AW, McArdle PD, Hughes AE, Emery VC, Griffiths PD (2003). Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control.. Xenotransplantation, 10(2), 142 - 148.
    • Davison AJ, Akter P, Cunningham C, Dolan A, Addison C, Dargan DJ, Hassan-Walker AF, Emery VC, Griffiths PD, Wilkinson GWG (2003). Homology between the human cytomegalovirus PL11 gene family and human adenovirus E3 genes. J GEN VIROL, 84, 657 - 663. doi:10.1099/vir.0.18856-0
    • Griffiths P (2003). The indirect effects of virus infections. Reviews in Medical Virology, 13(1), 1 - 3. doi:10.1002/rmv.385
    • Clark DA, Griffiths PD (2003). Human herpesvirus 6: Relevance of infection in the immunocompromised host. BRIT J HAEMATOL, 120(3), 384 - 395.
    • Akter P, Cunningham C, McSharry BP, Dolan A, Addison C, Dargan DJ, Hassan-Walker AF, Emery VC, Griffiths PD, Wilkinson GW, Davison AJ (2003). Two novel spliced genes in human cytomegalovirus. Journal of General Virology, 84, 1117 - 1122. doi:10.1099/vir.0.18952-0
    • Temperton NJ, Quenelle DC, Lawson KM, Zuckerman J, N K, E G, P D E, V C (2003). Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminium phosphate and CpG oligodeoxynucleotides (ODN).. Journal of Medical Virology, 70(1), 86 - 90.
    • Griffiths PD (2003). An earlier role for viral pharmacodynamics. Reviews in Medical Virology, 13(3), 135 - 136. doi:10.1002/rmv.394
    • Griffiths PD (2003). Therapeutic patents for cytomegalovirus. EXPERT OPIN THER PAT, 13(3), 319 - 327.

    2002

    • Griffiths PD (2002). Opening the Gates for vaccine development in the real world. Reviews In Medical Virology, 12(2), 67 - 68.
    • Griffiths PD (2002). The treatment of cytomegalovirus infection. Journal of Antimicrobial Chemotherapy, 49(2), 243 - 253.
    • Fiddian P, Sabin CA, Griffiths PD (2002). Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. The Journal of Infectious Diseases, 186(Suppl 1), S110 - S115.
    • Griffiths PD (2002). Tomorrow's Challenges for Herpesvirus Management: Potential Applications of Valacyclovir. The Journal of Infectious Diseases, 186 Su, S131 - S137.
    • Griffiths PD (2002). Strategies to prevent CMV infection in the neonate.. Semin Neonatol, 7(4), 293 - 299.
    • Griffiths PD (2002). Interactions between viral and human genes. Reviews In Medical Virology, 12(4), 197 - 199.
    • Emery VC, Hassan-Walker AF, Burroughs AK, Griffiths PD (2002). Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. The Journal of Infectious Diseases, 185(12), 1723 - 1728.
    • Nokta MA, Holland F, De G, V E, V C J, M A G, P P, R B F, J E (2002). Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease. The Journal of Infectious Diseases, 185(12), 1717 - 1722.
    • Griffiths PD (2002). Benefits of bioterrorism. Reviews In Medical Virology, 12(3), 131 - 132.
    • Ljungman P, Griffiths P, Paya C (2002). Definitions of cytomegalovirus infection and disease in transplant recipients. Clinical Infectious Diseases, 34(8), 1094 - 1097.
    • Jabs DA, Griffiths PD (2002). Fomivirsen for the treatment of cytomegalovirus retinitis. American Journal of Ophthalmology, 133(4), 552 - 556.
    • Griffiths PD (2002). The 2001 Garrod lecture. The treatment of cytomegalovirus infection. Journal of Antimicrobial Chemotherapy, 49(2), 243 - 253.
    • Deayton JR, Sabin CA, Britt WB, Jones IM, Wilson P, Johnson MA, Griffiths PD, Emery VC (2002). Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS, 16(16), 2129 - 2135.
    • Griffiths PD (2002). Preparing to treat prions. Reviews In Medical Virology, 12(1), 1 - 3.
    • Griffiths PD (2002). Resistance in viruses other than HIV. International Journal of Infectious Diseases, 6 Supp, S32 - S37.
    • Hassan-Walker AF, Emery VC, Griffiths PD (2002). Molecular diagnosis of cytomegalovirus disease.
    • Griffiths PD (2002). Facilitating viral recombination. Reviews in Medical Virology, 12(6), 335 - 336. doi:10.1002/rmv.374

    2001

    • Griffiths PD (2001). Cytomegalovirus therapy: current constraints and future opportunities.. Curr Opin Infect Dis, 14(6), 765 - 768.
    • Prentice HG, Potter MN, Mattes FM, Hainsworth E, Murdin-Geretti A, Nebbia G, Burroughs AK, Sweeny P, Hassan-Walker AF, Okwuadi S, Emery VC, Griffiths PD (2001). A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients.. BLOOD, 98(11), 395A - 395A.
    • McKnight A, Griffiths DJ, Dittmar M, Clapham P, Thomas E (2001). Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2. Journal of Virology, 75(15), 6914 - 6922.
    • Fryer J, Tucker D, Hughes A, Emery V, Griffiths P, Clark D (2001). Porcine cytomegalovirus in pigs being bred for xenograft organs: prospects for eradication. XENOTRANSPLANTATION, 8, 15 - 15.
    • Griffiths PD (2001). Herpesviruses in the era of highly active antiretroviral therapy. Herpes, 8(2), 31 - 31.
    • Hassan-Walker AF, Vargas Cuero AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK, Griffiths PD, Phillips RE, Emery VC (2001). CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus. The Journal of Infectious Diseases, 183(6), 835 - 843.
    • Fryer JF, Griffiths PD, Fishman JA, Emery VC, Clark DA (2001). Quantitation of porcine cytomegalovirus in pig tissues by PCR.. J Clin Microbiol, 39(3), 1155 - 1156. doi:10.1128/JCM.39.3.1155-1156.2001
    • Griffiths P, McLean A, Emery VC (2001). Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine, 19(11-12), 1356 - 1362. doi:10.1016/S0264-410X(00)00377-7
    • Hassan-Walker AF, Mattes FM, Griffiths PD, Emery VC (2001). Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts.. J Med Virol, 64(3), 283 - 289.

    2000

    • Emery VC, Sabin CA, Hassan-Walker AF, Griffiths PD (2000). Viral-load kinetics and CMV disease - Reply. The Lancet, 356(9238), 1353 - 1353.
    • Griffiths PD (2000). Size is important (and so are quality and style) [editorial]. Reviews In Medical Virology, 10, 1 - .
    • Griffiths PD (2000). When is a sexually transmitted viral disease not an 'STD'?. Reviews In Medical Virology, 10(2), 71 - 73.
    • Deayton JR, Shannon-Lowe C, Wilson P, Johnson MA, Griffiths PD, Emery VC (2000). Recurrence of CMV viraemia and development of anti-CMV drug resistance in patients receiving highly active antiretroviral therapy after CMV retinitis. AIDS, 14, L542 - .
    • Deayton JR, Sabin CA, Johnson MA, Griffiths PD, Emery VC (2000). Efficacy of the regenerating immune system in the inhibition of CMV replication after highly active antiretroviral therapy (HAART)). AIDS, 14, S5 - S5.
    • Deayton JR, Shannon-Lowe C, Wilson P, Johnson MA, Griffiths PD, Emery VC (2000). Recurrence of CMV viraemia and development of anti-CMV drug resistance in patients receiving highly active antiretroviral therapy after CMV retinitis. AIDS, 14, S5 - S6.
    • Lipman MCI, Ainscough S, Deery ARS, Griffiths PD, Johnson MA, Kibbler CC (2000). Infrequency of pulmonary microbial colonisation prior to respiratory disease in HIV-infected individuals. European Journal of Clinical Microbiology and Infectious Diseases, 19(9), 699 - 703.
    • Mattes FM, McLaughlin JE, Emery VC, Clark DA, Griffiths PD (2000). Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7. Journal of Clinical Pathology, 53(8), 612 - 614.
    • Emery VC, Griffiths PD (2000). Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proceedings of the National Academy of Sciences of the United States of America, 97(14), 8039 - 8044.
    • Hassan-Walker AF, Vargas AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK, Griffiths PD, Phillips RE, Emery VC (2000). Immunosuppression for liver transplantation with tacrolimus impairs specific cytomegalovirus CD8 immune responses. CLIN INFECT DIS, 31(1), 317 - 317.
    • Deayton JR, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC, Griffiths PD (2000). Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS, 14(9), 1163 - 1170.
    • Kidd IM, Clark DA, Sabin CA, Andrew D, Hassan-Walker AF, Sweny P, Griffiths PD, Emery VC (2000). Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation, 69(11), 2400 - 2404.
    • Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000). Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. The Lancet, 355(9220), 2032 - 2036.
    • Sabin CA, Devereux HL, Clewley G, Emery VC, Phillips AN, Loveday C, Lee CA, Griffiths PD (2000). Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia. The Journal of Infectious Diseases, 181(5), 1800 - 1803.
    • Griffiths PD, Clark DA, Emery VC (2000). Betaherpesviruses in transplant recipients. Journal of Antimicrobial Chemotherapy, 45(Suppl), 29 - 34.
    • Clark DA, Griffiths PD, Emery VC (2000). Newer human herpesviruses in transplantation. Current Opinion in Organ Transplantation, 5, 203 - 209.
    • Cockcroft A, Griffiths PD (2000). Acquired Immune Deficiency Syndrome. In Cox RAF, Edwards FC, Palmer K (Ed.), Fitness for Work: the Medical Aspects (pp. 463 - 479). : Oxford University Press.
    • Deayton JR, Sabin CA, Johnson MA, Griffiths PD, Emery VC (2000). Efficacy of the regenerating immune system in the inhibition of CMV replication after highly active antiretroviral therapy (HAART)). AIDS, 14, L541 - .
    • Deayton JR, Griffiths PD (2000). When can cytomegalovirus prophylaxis and maintenance therapy be stopped in HIV disease?. Current Opinion in Infectious Diseases, 13(6), 637 - 641.
    • Griffiths P (2000). Strengths and limitations of therapies for genital herpes - preclinical aspects.
    • Griffiths PD (2000). Biological synergism between infectious agents [editorial]. Reviews In Medical Virology, 10, 351 - 353.
    • Griffiths PD (2000). Cytomegalovirus. In Zuckerman AJ, Banatvala JE, Pattison JR (Ed.), Principles and Practice of Clinical Virology (pp. 79 - 115). : Wileys.
    • Griffiths PD (2000). Herpesviruses as unrecognised components of the pathogenesis of chronic diseases [editorial]. Reviews of Medical Virology, 10, 281 - 283.
    • Griffiths PD (2000). Is virology cost-effective [editorial]. Reviews In Medical Virology, 10, 139 - 140.
    • Griffiths PD (2000). Science before the CD-ROM [editorial]. Reviews In Medical Virology, 10, 205 - 206.
    • Griffiths PD (2000). Xenotransplantation: one trotter forward, one claw back. The Lancet, 356(9235), 1049 - 1050.
    • Hassan-Walker AF, Vargas AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK, Griffiths PD, Phillips RE, Emery VC (2000). Immunosuppression for liver transplantation with tacrolimus impairs specific cytomegalovirus CD8 immune responses. Clinical Infectious Diseases, 31(1), 602 - .
    • Kuo Y-H, Kuo Y-L, Emery VC, Sabin CA, Hassan-Walker AF, Griffiths PD (2000). Viral-load kinetics and CMV disease [3] (multiple letters). Lancet, 356(9238), 1352 - 1353.

    1999

    • Hassan-Walker AF, Kidd IM, Sabin C, Sweny P, Griffiths PD, Emery VC (1999). Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG). Journal of Medical Virology, 58(2), 182 - 187.
    • Sabin CA, Clewley GS, Deayton JR, Mocroft A, Johnson MA, Lee CA, McLaughlin JE, Griffiths PD (1999). Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract. Journal of Medical Virology, 58(3), 280 - 285.
    • Griffiths PD, Cope AV, Hassan-Walker AF, Emery VC (1999). Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation.. Transpl Infect Dis, 1(3), 179 - 186.
    • Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, Burroughs AK, Rolles K, Kidd IM, Knight SN, Noibi SM, Cope AV, Phillips AN, Emery VC (1999). Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. Journal of Medical Virology, 59(4), 496 - 501.
    • Emery VC, Atkins MC, Bowen EF, Clark DA, Johnson MA, Kidd IM, McLaughlin JE, Phillips AN, Strappe PM, Griffiths PD (1999). Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. Journal of Medical Virology, 57(3), 278 - 282. doi:10.1002/(SICI)1096-9071(199903)57:3<278::AID-JMV11>3.0.CO;2-3
    • Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, Griffiths PD (1999). Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. The Journal of Infectious Diseases, 180(3), 695 - 701.
    • Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD (1999). Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. AIDS, 13(10), 1203 - 1206. doi:10.1097/00002030-199907090-00008
    • Efstathiou S, Field HJ, Griffiths PD, Kern ER, Sacks SL, Sawtell NM, Stanberry LR (1999). Herpes simplex virus latency and nucleoside analogues. ANTIVIR RES, 41(3), 85 - 100.
    • Pawson R, Potter M, Geretti AM, Griffiths P, Prentice HG (1999). Combined foscarnet and ganciclovir at half doses for the pre-emptive treatment of CMV infection: A pilot study.. BRIT J HAEMATOL, 105, 59 - 59.
    • Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD (1999). The dynamics of human cytomegalovirus replication in vivo.. J Exp Med, 190(2), 177 - 182.
    • Bowen EF, Cherrington JM, Lamy PD, Griffiths PD, Johnson MA, Emery VC (1999). Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.. J Med Virol, 58(4), 402 - 407.
    • Goebel FD, Mannhalter JW, Belshe RB, Eibl MM, Grob PJ, de Gruttolae V, Griffiths PD, Erfle V, Kunschak M, Engl W, European Multinational IMMUNO AIDS Vaccine (1999). Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. AIDS, 13(12), 1461 - 1468.
    • Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF (1999). Asymptomatic primary cytomegalovirus infection: Virologic and immunologic features.
    • Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, Griffiths PD, AIDS Clinical Trials Grp 204 , Glaxo Wellcome 123-014 Int CMV Prophylaxis Stud (1999). Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: Baseline CMV load dictates time to disease and survival. J INFECT DIS, 180(3), 695 - 701.
    • Grzywacz M, Deayton JR, Bowen EF, Wilson P, Emery VC, Johnson MA, Griffiths PD (1999). Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.. J Med Virol, 59(3), 323 - 328.
    • Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA (1999). Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA-J AM MED ASSOC, 282(17), 1633 - 1637.
    • Griffiths PD (1999). Defending vaccines from the enemy within. Reviews in Medical Virology, 9(3), 145 - 146. doi:10.1002/(SICI)1099-1654(199907/09)9:3<145::AID-RMV257>3.0.CO;2-P
    • Griffiths PD (1999). Destruction of smallpox stocks. Reviews in Medical Virology, 9(4), 217 - 218. doi:10.1002/(SICI)1099-1654(199910/12)9:4<217::AID-RMV263>3.0.CO;2-E

    1998

    • Bowen EF, Emery VC, Wilson P, Johnson MA, Davey CC, Sabin CA, Farmer D, Griffiths PD (1998). Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS, 12(6), 605 - 611.
    • de Jong MD, Boucher CAB, Danner SA, Gazzard B, Griffiths PD, Katlama C, Lange JMA, Richman DD, Vella S (1998). Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections. ANTIVIR RES, 37(1), 1 - 16.
    • Griffiths PD (1998). Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo. J GEN VIROL, 79, 213 - 220.
    • Griffiths PD, Feinberg JE, Fry J, Sabin C, Dix L, Gor D, Ansari A, Emery VC (1998). The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. The Journal of Infectious Diseases, 177(1), 57 - 64.
    • de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA (1998). Summary of the II International Symposium on Cytomegalovirus. ANTIVIR RES, 39(3), 141 - 162.
    • Rankin PF, Prentice HG, Moore J, Clark DA, Potter M, Knight SN, Sabin CA, Mattes FM, Noibi SN, Emery VC, Griffiths PD (1998). Significance of quantitative-competitive PCR for human herpes virus-6, human herpes virus-7 and cytomegalovirus following bone marrow transplantation.. BLOOD, 92(10), 518A - 518A.
    • Atkins M, Strappe P, McLaughlin JE, Johnson MA, Griffiths PD, Emery VC, Loveday C, Kaye S, Tedder RS (1998). Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients. Journal of Medical Virology, 55(2), 138 - 146. doi:10.1002/(SICI)1096-9071(199806)55:2<138::AID-JMV10>3.0.CO;2-E
    • Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, Holland GN, Griffiths PD, Pollard RB, Youle M, Gill MJ, Holland FJ, Power ME, Owens S, Coakley D, Fry J, Jacobson MA (1998). A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection.
    • Hassan-Walker AF, Cope AV, Griffiths PD, Emery VC (1998). Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo.. J Gen Virol, 79 ( Pt 9), 2113 - 2116.
    • Ioannidis JPA, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle MS (1998). Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: A meta-analysis of randomized individual patient data.
    • Griffiths P (1998). Herpes/HIV/hepatitis viruses: biological similarities despite taxonomic differences.. Rev Med Virol, 8(3), 117 - 118.
    • Kidd IM, Clark DA, Bremner JA, Pillay D, Griffiths PD, Emery VC (1998). A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products.. J Virol Methods, 70(1), 29 - 36.
    • Griffiths PD (1998). Human herpes viruses-6, -7 and -8.. Neth J Med, 52(6), 257 - 260.
    • Pawson R, Moore J, Potter M, Geretti AM, Griffiths P, Prentice HG (1998). Treatment of CMV infections after allogeneic BMT with combination of half-dose ganciclovir plus foscarnet.. BLOOD, 92(10), 282A - 282A.
    • Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA, Int AIDS Society (1998). Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy - Recommendations of an international panel. ARCH INTERN MED, 158(9), 957 - 969.
    • Griffiths PD, Feinberg JE, Fry J, Sabin C, Dix L, Gor D, Ansari A, Emery VC (1998). The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease.
    • Griffiths P (1998). Update on herpesvirus infections.. J R Coll Physicians Lond, 32(3), 199 - 202.
    • Gor D, Sabin C, Prentice HG, Vyas N, Man S, Griffiths PD, Emery VC, Cozzi-Lepri A, Smith GD, Mocroft A, Sabin CA, Morris RW, Phillips AN (1998). Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplantation, 21(6), 597 - 605.

    1997

    • Lao WC, Lee D, Burroughs AK, Lanzani G, Rolles K, Emery VC, Griffiths PD (1997). Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation.. J Med Virol, 51(3), 152 - 158.
    • Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC (1997). Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation.. J Infect Dis, 176(6), 1484 - 1490.
    • Clark DA, Michael Kidd I, Griffiths PD, Emery VC, Collingham KE, Pillay D, Tarlow M, Ayeni T, Riordan A (1997). Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction. Archives of Disease in Childhood, 77(1), 42 - 45.
    • Quaglia A, Bearcroft CP, Griffiths PD, Burroughs AK, Davies SE (1997). Is human herpes virus-6 & 7 in the post-transplant liver as pathogenic as cytomegalovirus?. J PATHOL, 181, A48 - A48.
    • Griffiths P (1997). The herpesvirus family in the 21st century. ANTIVIR CHEM CHEMOTH, 8, 11 - 15.
    • Cope AV, Sweny P, Sabin CA, Rees L, Griffiths PD, Emery VC (1997). Quantity of Cytomegalovirus viruia Is a major risk factor for Cytomegalovirus disease after renal transplantation. Journal of Medical Virology, 52(2), 200 - 205.
    • Bowen EF, Sabin CA, Wilson P, Griffiths PD, Davey CC, Johnson MA, Emery VC (1997). Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS, 11(7), 889 - 893.
    • Griffiths PD (1997). Prophylaxis against CMV infection in transplant patients.. J Antimicrob Chemother, 39(3), 299 - 301.
    • Phillips AN, McLean A, Johnson MA, Tyrer M, Emery V, Griffiths P, Bofill M, Janossy G, Loveday C (1997). HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management. Journal of Medical Virology, 53(3), 261 - 265.
    • Bowen EF, Johnson MA, Griffiths PD, Emery VC (1997). Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance.. J Virol Methods, 68(2), 225 - 234.
    • Fabio G, Knight SN, Kidd IM, Noibi SM, Johnson MA, Emery VC, Griffiths PD, Clark DA (1997). Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patients.. J Clin Microbiol, 35(10), 2657 - 2659.

    1996

    • Kidd IM, Clark DA, Ait-Khaled M, Griffiths PD, Emery VC (1996). Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction.. J Infect Dis, 174(2), 396 - 401.
    • Griffiths PD, Whitley RD (1996). The pathogenesis of AIDS: Lessons learned from other medical conditions. INFECT AGENT DIS, 5(4), 231 - 239.
    • Goebel FD, Mannhalter JW, Eibl MM, Belshe RB, Grob P, Erfle V, Griffiths PD, Wahren B, Krohn K, Kunschak M, Engl W (1996). Multicenter study of safety and immunogenicity of HIV-1 rgp160 candidate vaccine in seropositive HIV-1 volunteers.. AIDS, 10, OP64 - OP64.
    • vanderMeer JTM, Drew WL, Bowden RA, Galasso GJ, Griffiths PD, Jabs DA, Katlama C, Spector SA, Whitley RJ (1996). Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis of Cytomegalovirus Infection. ANTIVIR RES, 32(3), 119 - 140.
    • Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA (1996). Lessons from the natural history of cytomegalovirus.. AIDS, 10 Suppl 1, S37 - S41.
    • Griffiths PD (1996). Herpesviruses and AIDS. Journal of Antimicrobial Chemotherapy, 37(SUPPL. B), 87 - 95.
    • James E, Robinson L, Griffiths PD, Prentice HG (1996). Acute myeloblastic leukaemia presenting with herpes simplex type-1 viraemia and pneumonia.. Br J Haematol, 93(2), 401 - 402.
    • Griffiths PD (1996). Herpesviruses and AIDS.. Scand J Infect Dis Suppl, 100, 3 - 7.
    • Bowen EF, Wilson P, Cope A, Sabin C, Griffiths P, Davey C, Johnson M, Emery V (1996). Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival.. AIDS, 10(13), 1515 - 1520.

    1995

    • GRIFFITHS PD (1995). PARAMETERS FOR THE SUCCESSFUL MANAGEMENT OF CYTOMEGALOVIRUS.
    • GRIFFITHS PD (1995). A PROPOSAL THAT HERPESVIRUSES ARE COFACTORS OF HIV DISEASE.
    • Griffiths PD (1995). Interaction between herpesviruses and HIV. Current Opinion in Infectious Diseases, 8(6), 479 - 482. doi:10.1097/00001432-199512000-00014
    • GRIFFITHS PD (1995). Problems with resistance, and what is in the pipeline for treatment of cytomegalovirus.
    • Fox JC, Kidd IM, Griffiths PD, Sweny P, Emery VC (1995). Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. Journal of General Virology, 76, 309 - 319. doi:10.1099/0022-1317-76-2-309
    • Bowen EF, Wilson P, Atkins M, Madge S, Griffiths PD, Johnson MA, Emery VC (1995). Natural history of untreated cytomegalovirus retinitis.. Lancet, 346(8991-8992), 1671 - 1673.
    • GRIFFITHS PD (1995). VIRAL COMPLICATIONS AFTER TRANSPLANTATION.
    • GRIFFITHS PD (1995). PROGRESS IN THE CLINICAL MANAGEMENT OF HERPESVIRUS INFECTIONS. ANTIVIR CHEM CHEMOTH, 6(4), 191 - 209.
    • Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD (1995). The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiology and Infection, 114(2), 361 - 372. doi:10.1017/S095026880005799X
    • Webster A, McLaughlin JE, Johnson MA, Emery VC, Griffiths PD (1995). Use of the polymerase chain reaction to detect genomes of human immunodeficiency virus and cytomegalovirus in post-mortem tissues. Journal of Medical Virology, 47(1), 23 - 28.

    1994

    • YOULE MS, GAZZARD BG, JOHNSON MA, COOPER DA, HOY JF, BUSCH H, RUF B, GRIFFITHS PD, STEPHENSON SL, DANCOX M, BELL AR (1994). EFFECTS OF HIGH-DOSE ORAL ACYCLOVIR ON HERPESVIRUS DISEASE AND SURVIVAL IN PATIENTS WITH ADVANCED HIV DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. AIDS, 8(5), 641 - 649.
    • Phillips AN, Sabin CA, Elford J, Bofill M, Emery V, Griffiths PD, Janossy G, Lee CA (1994). Viral burden in HIV infection. Nature, 367(6459), 124 - 124. doi:10.1038/367124a0
    • Downey GP, Bavin PJ, Deery AR, Crow J, Griffiths PD, Emery VC, Walker PG (1994). Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. The Lancet, 344(8920), 432 - 435. doi:10.1016/S0140-6736(94)91768-X
    • GRIFFITHS PD (1994). SPECTRUM OF ACTIVITY OF ANTIHERPESVIRUS DRUGS.
    • Griffiths PD (1994). Evaluating new antiviral drugs: Closing remarks. Antiviral Chemistry and Chemotherapy, Supplement, 5(1), 39 - 39.
    • Griffiths PD, Emery VC, Lee C, Johnson MA, McLaughlin J (1994). HHV-6 in AIDS. The Lancet, 343(8905), 1104 - 1105. doi:10.1016/S0140-6736(94)90218-6
    • Zuckerman JN, Clewley G, Griffiths P, Cockcroft A (1994). Prevalence of hepatitis C antibodies in healthcare workers. The Lancet, 343, 1618 - 1620.

    1993

    • Webster A, Blizzard B, Pillay D, Prentice HG, Pothecary K, Griffiths PD (1993). Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantation.. Bone Marrow Transplant, 12(5), 477 - 481.
    • RABKIN CS, HATZAKIS A, GRIFFITHS PD, PILLAY D, RAGNI MV, HILGARTNER MW, GOEDERT JJ (1993). CYTOMEGALOVIRUS-INFECTION AND RISK OF AIDS IN HUMAN-IMMUNODEFICIENCY-VIRUS - INFECTED HEMOPHILIA PATIENTS. J INFECT DIS, 168(5), 1260 - 1263.
    • Roy DM, Brenner MK, Cook D, Duncan RI, Griffiths PD, Grundy JE (1993). Transfer of humoral immunity against cytomegalovirus proteins following transplantation of T-cell-depleted allogeneic bone marrow from seropositive donors.. J Med Virol, 41(2), 150 - 158.
    • Pillay D, Ali AA, Liu SF, Kops E, Sweny P, Griffiths PD (1993). The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients.. Transplantation, 56(1), 103 - 108.
    • Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C (1993). The progression of HIV disease in a haemophilic cohort followed for 12 years.. Br J Haematol, 83(2), 330 - 333.
    • Iragorri S, Pillay D, Scrine M, Trompeter RS, Rees L, Griffiths PD (1993). Prospective cytomegalovirus surveillance in paediatric renal transplant patients.. Pediatr Nephrol, 7(1), 55 - 60.
    • Griffiths PD, Whitley RJ (1993). Viral infections in the immunocompromised host. Current Opinion in Infectious Diseases, 6(3), 417 - 421.
    • Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC, Walker PG (1993). Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. British Journal of Cancer, 67(3), 602 - 605.
    • Pillay D, Lipman MCI, Lee CA, Johnson MA, Griffiths PD, McLaughlin JE (1993). A Clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS, 7, 969 - 974.
    • Griffiths PD (1993). Current management of cytomegalovirus disease.. J Med Virol, Suppl 1, 106 - 111.
    • GRIFFITHS PD (1993). FUTURE MANAGEMENT OF HERPESVIRUS INFECTIONS.
    • Emery VC, Webster A, Griffiths PD (1993). Molecular and cell biology of opportunistic infections in AIDS. Herpesviruses.. Molecular and cell biology of human diseases series, 2, 257 - 277.
    • Kidd IM, Fox JC, Pillay D, Charman H, Griffiths PD, Emery VC (1993). Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation, 56(4), 867 - 871.

    1992

    • Pillay D, Charman H, Lok J, Griffiths PD (1992). Detection of cytomegalovirus by a rapid culture system: a comparison of monoclonal antibodies in a clinical setting.. J Virol Methods, 40(2), 219 - 224.
    • Bagdades EK, Pillay D, Squire SB, O'Neil C, Johnson MA, Griffiths PD (1992). Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection.. AIDS, 6(11), 1317 - 1320.
    • GRIFFITHS PD (1992). STUDIES TO DEFINE VIRAL COFACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS. INFECT AGENT DIS, 1(5), 237 - 244.
    • Pillay D, Charman H, Burroughs AK, Smith M, Rolles K, Griffiths PD (1992). Surveillance for CMV infection in orthotopic liver transplant recipients.. Transplantation, 53(6), 1261 - 1265.
    • Pillay D, Griffiths PD (1992). Diagnosis of cytomegalovirus infection: a review.. Genitourin Med, 68(3), 183 - 188.
    • Lui SF, Ali AA, Grundy JE, Fernando ON, Griffiths PD, Sweny P (1992). Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients.. Nephrol Dial Transplant, 7(12), 1230 - 1237.
    • Fox JC, Griffiths PD, Emery VC (1992). Quantification of human cytomegalovirus DNA using the polymerase chain reaction. Journal of General Virology, 73(9), 2405 - 2408. doi:10.1099/0022-1317-73-9-2405
    • Bavin PJ, Giles JA, Hudson E, Williams D, Crow J, Griffiths PD, Emery VC, Walker PG (1992). Comparison of cervical cytology and the polymerase chain reaction for HPV 16 to identify women with cervical disease in a general practice population. Journal of Medical Virology, 37(1), 8 - 12. doi:10.1002/jmv.1890370103
    • Squire SB, Lipman MCI, Bagdades EK, Mulvenna PM, Grundy JE, Griffiths PD (1992). Severe CMV pneumonitis in HIV infected patients with higher than average CD4 counts. Thorax, 47, 301 - 304.
    • WEBSTER A, PHILLIPS A, LEE C, al. E (1992). CYTOMEGALOVIRUS (CMV) INFECTION, CD4+ LYMPHOCYTE COUNTS AND THE DEVELOPMENT OF AIDS IN HIV-1-INFECTED HEMOPHILIAC PATIENTS. , 88(1), 6 - 9.
    • Pillay D, Webster A, Prentice HG, Griffiths PD (1992). Risk factors for viral reactivation following bone marrow transplantation.. Ann Hematol, 64 Suppl, A148 - A151.

    1991

    • SMITH M, PILLAY DR, CHARMAN D, GRIFFITHS PD, ROLLES K, BURROUGHS AK (1991). SURVEILLANCE FOR CYTOMEGALOVIRUS-INFECTION USING CULTURE TECHNIQUES IN LIVER-TRANSPLANT RECIPIENTS. GUT, 32(10), A1250 - A1250.
    • Griffiths PD (1991). Advances in the prevention and treatment of cytomegalovirus infection in hospital patients.. J Hosp Infect, 18 Suppl A, 330 - 334.
    • Pillay D, Webster A, Lee D, Prentice HG, Griffiths PD (1991). Cytomegalovirus excretion after bone marrow transplantation cannot be predicted from the pre-transplant level of IgG antibodies.. J Med Virol, 33(4), 257 - 259.
    • PHILLIPS A, LEE C, ELFORD J, al. E (1991). P24 ANTIGENEMIA, CD4 LYMPHOCYTE COUNTS AND THE DEVELOPMENT OF AIDS. , 5(10), 1217 - 1222.
    • Darlington J, Super M, Patel K, Grundy JE, Griffiths PD, Emery VC (1991). Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. Journal of General Virology, 72(8), 1985 - 1989. doi:10.1099/0022-1317-72-8-1985
    • McLean AR, Emery VC, Webster A, Griffiths PD (1991). Population dynamics of HIV within an individual after treatment with zidovudine. AIDS, 5(5), 485 - 489.
    • LEE C, PHILLIPS A, ELFORD J, al. E (1991). PROGRESSION OF HIV DISEASE IN A HEMOPHILIC COHORT FOLLOWED FOR 11 YEARS AND THE EFFECT OF TREATMENT. , 303(6810), 1093 - 1096.
    • Griffiths PD, Baboonian C, Rutter D, Peckham C (1991). Congenital and maternal cytomegalovirus infections in a London population.. Br J Obstet Gynaecol, 98(2), 135 - 140.

    1990

    • Emery VC, Griffiths PD (1990). Molecular biology of cytomegalovirus.. Int J Exp Pathol, 71(6), 905 - 918.
    • Griffiths PD, Ellis DS, Zuckerman AJ (1990). Other common types of viral hepatitis and exotic infections.. Br Med Bull, 46(2), 512 - 532.
    • Emery VC, Griffiths PD (1990). Molecular biology of cytomegalovirus.. International journal of experimental pathology, 71(6), 905 - 918.
    • Griffiths PD (1990). Virus infections in patients with AIDS.. Trans R Soc Trop Med Hyg, 84 Suppl 1, 7 - 8.
    • MCKEATING JA, GRIFFITHS PD, WEISS RA (1990). HIV SUSCEPTIBILITY CONFERRED TO HUMAN FIBROBLASTS BY CYTOMEGALOVIRUS-INDUCED FC RECEPTOR. NATURE, 343(6259), 659 - 661.

    1989

    • Griffiths PD (1989). Diagnosis of cytomegalovirus infection.. J Antimicrob Chemother, 23 Suppl E, 11 - 16.
    • Baboonian C, Grundy JE, Lever AM, Griffiths PD (1989). Effect of pregnancy plasma upon in vitro parameters of cell mediated immunity.. FEMS Microbiol Immunol, 1(4), 189 - 197.
    • Webster A, Grint P, Brenner MK, Prentice HG, Griffiths PD (1989). Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster.. J Med Virol, 27(2), 117 - 119.
    • Grundy JE, Griffiths PD (1989). Acyclovir to prevent cytomegalovirus infection in renal-graft recipients. New England Journal of Medicine, 321(18), 1268 - 1269.
    • Webster A, Grundy JE, Lee CA, Emery VC, Cook DG, Kernoff PB, Griffiths PD (1989). Cytomegalovirus infection and progression to AIDS. The Lancet, 334(8664), 681 - 681. doi:10.1016/S0140-6736(89)90928-8
    • Griffiths PD, Grundy JE (1989). Rapid early diagnosis of cytomegalovirus infection.. Folia Haematol Int Mag Klin Morphol Blutforsch, 116(3-4), 553 - 555.
    • Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PB, Griffiths PD (1989). Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. The Lancet, 334(8654), 63 - 66. doi:10.1016/S0140-6736(89)90312-7

    1988

    • Milburn HJ, Grundy JE, du Bois RM, Prentice HG, Griffiths PD (1988). Is the measurement of virus-specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or prognostic value?. J Med Virol, 26(2), 197 - 206.
    • Griffiths PD (1988). Chronic cytomegalovirus infection.. J Virol Methods, 21(1-4), 79 - 86.
    • Grundy JE, Ayles HM, McKeating JA, Butcher RG, Griffiths PD, Poulter LW (1988). Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection.. J Med Virol, 25(4), 483 - 495.
    • Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, Moorhead J, Griffiths PD (1988). Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.. Lancet, 2(8603), 132 - 135.
    • Grundy JE, McKeating JA, Sanderson AR, Griffiths PD (1988). Cytomegalovirus and beta 2 microglobulin in urine specimens. Reciprocal interference in their detection is responsible for artifactually high levels of urinary beta 2 microglobulin in infected transplant recipients.. Transplantation, 45(6), 1075 - 1079.
    • Griffiths PD, Grundy JE, Ali A, Sweny P, Trompeter RS, Fernando ON, Moorhead J (1988). Cytomegalovirus matching in renal transplantation. Lancet, 2(8617), 971 - 971.
    • Berry NJ, Burns DM, Wannamethee G, Grundy JE, Lui SF, Prentice HG, Griffiths PD (1988). Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases.. J Med Virol, 24(4), 385 - 393.
    • Griffiths PD, Grundy JE (1988). The status of CMV as a human pathogen.. Epidemiol Infect, 100(1), 1 - 15. doi:10.1017/S095026880006550X
    • Snoeck R, Griffiths PD (1988). Herpes virus infections.. J Hosp Infect, 11 Suppl A, 29 - 36.
    • Lever AM, Milburn HJ, du Bois RM, Griffiths PD, Grundy JE (1988). Presence of a partially acid-labile alpha-interferon in bronchoalveolar lavage fluid of patients with cytomegalovirus pneumonitis is associated with a poor prognosis.. J Med Virol, 24(1), 67 - 73.
    • Griffiths PD (1988). Cytomegalovirus infection complicating immunosuppressive treatment.. Postgrad Med J, 64(747), 1 - 3.
    • Stirk PR, Griffiths PD (1988). Comparative sensitivity of three methods for the diagnosis of cytomegalovirus lung infection.. J Virol Methods, 20(2), 133 - 141.

    1987

    • AHLFORS K, FORSGREN M, GRIFFITHS P, NIELSEN CM (1987). COMPARISON OF 4 SEROLOGICAL TESTS FOR THE DETECTION OF SPECIFIC IMMUNOGLOBULIN-M IN CORD SERA OF INFANTS CONGENITALLY INFECTED WITH CYTOMEGALOVIRUS. SCAND J INFECT DIS, 19(3), 303 - 308.
    • GRIFFITHS PD, GRUNDY JE (1987). MOLECULAR-BIOLOGY AND IMMUNOLOGY OF CYTOMEGALOVIRUS. BIOCHEM J, 241(2), 313 - 324.
    • Grundy JE, Shanley JD, Griffiths PD (1987). Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?. Lancet, 2(8566), 996 - 999.
    • Wimperis JZ, Berry NJ, Prentice HG, Lever A, Griffiths PD, Brenner MK (1987). Regeneration of humoral immunity to herpes simplex virus following T-cell-depleted allogeneic bone marrow transplantation.. J Med Virol, 23(1), 93 - 99.
    • BRENNER MK, GRIFFITHS PD, PRENTICE HG (1987). CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION. LANCET, 2(8553), 286 - 287.
    • GROB JP, PRENTICE HG, HOFFBRAND AV, TATE T, GRUNDY JE, GRIFFITHS PD, HUGHES MD, WIMPERIS JZ, BRENNER MK (1987). IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS. LANCET, 1(8536), 774 - 776.
    • STIRK PR, GRIFFITHS PD (1987). USE OF MONOCLONAL-ANTIBODIES FOR THE DIAGNOSIS OF CYTOMEGALOVIRUS-INFECTION BY THE DETECTION OF EARLY ANTIGEN FLUORESCENT FOCI (DEAFF) IN CELL-CULTURE. J MED VIROL, 21(4), 329 - 337.
    • GRUNDY JE, MCKEATING JA, GRIFFITHS PD (1987). CYTOMEGALOVIRUS STRAIN AD169 BINDS BETA-2 MICROGLOBULIN INVITRO AFTER RELEASE FROM CELLS. J GEN VIROL, 68, 777 - 784.
    • MCKEATING JA, GRIFFITHS PD, GRUNDY JE (1987). CYTOMEGALOVIRUS IN URINE SPECIMENS HAS HOST BETA-2 MICROGLOBULIN BOUND TO THE VIRAL ENVELOPE - A MECHANISM OF EVADING THE HOST IMMUNE-RESPONSE. J GEN VIROL, 68, 785 - 792.
    • GRUNDY JE, MCKEATING JA, WARD PJ, SANDERSON AR, GRIFFITHS PD (1987). BETA-2 MICROGLOBULIN ENHANCES THE INFECTIVITY OF CYTOMEGALOVIRUS AND WHEN BOUND TO THE VIRUS ENABLES CLASS-I HLA MOLECULES TO BE USED AS A VIRUS RECEPTOR. J GEN VIROL, 68, 793 - 803.
    • Grundy JE, Super M, Lui S, Sweny P, Griffiths PD (1987). The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney.. Transplant Proc, 19(1 Pt 3), 2126 - 2128.
    • Lui SF, Sweny P, Grundy JE, Blaxill A, Griffiths PD, Moorhead JF, Fernando ON (1987). The clinical application of a rapid diagnostic test for the detection of cytomegalovirus infection in renal transplant recipients.. Transplant Proc, 19(1 Pt 3), 2129 - 2130.
    • ROSS MGR, BURNS DM, GRUNDY JE, GRIFFITHS PD (1987). INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) AND CYTOMEGALOVIRUS IN A LONDON HEALTH DISTRICT 1980-4. GENITOURIN MED, 63(1), 28 - 31.
    • BERRY NJ, GRUNDY JE, GRIFFITHS PD (1987). RADIOIMMUNOASSAY FOR THE DETECTION OF IGG ANTIBODIES TO HERPES-SIMPLEX VIRUS AND ITS USE AS A PROGNOSTIC INDICATOR OF HSV EXCRETION IN TRANSPLANT RECIPIENTS. J MED VIROL, 21(2), 147 - 154.
    • COATES PJ, HALL PA, DARDENNE AJ, BUTLER MG, GRINT PCA, SEQUIRA J, YOUNG B, GRIFFITHS PD (1987). THE DEMONSTRATION OF CYTOMEGALOVIRUS BY INSITU HYBRIDIZATION - A POTENTIALLY VALUABLE DIAGNOSTIC-TOOL. J PATHOL, 151(1), A99 - A99.

    1986

    • GRIFFITHS PD, STIRK PR, BLACKLOCK HA, DUBOIS RM, PRENTICE HG (1986). RAPID DIAGNOSIS AND TREATMENT OF CYTOMEGALOVIRUS PNEUMONITIS. J CELL BIOCHEM, , 255 - 255.
    • Trompeter RS, Bradley JM, Griffiths PD (1986). Varicella zoster in the newborn. Lancet, 1(8483), 744 - 744.
    • GRUNDY JE, SUPER M, GRIFFITHS PD (1986). REINFECTION OF A SEROPOSITIVE ALLOGRAFT RECIPIENT BY CYTOMEGALOVIRUS FROM DONOR KIDNEY. LANCET, 1(8473), 159 - 160.
    • MCKEATING JA, GRUNDY JE, VARGHESE Z, GRIFFITHS PD (1986). DETECTION OF CYTOMEGALOVIRUS BY ELISA IN URINE SAMPLES IS INHIBITED BY BETA-2 MICROGLOBULIN. J MED VIROL, 18(4), 341 - 348.
    • LEVER AML, MILBURN HJ, GRUNDY JE, PRATT P, GRIFFITHS PD, DUBOIS RM (1986). LOCAL PRODUCTION OF ALPHA INTERFERON IN CYTOMEGALOVIRUS PNEUMONITIS. THORAX, 41(9), 730 - 730.
    • BERRY NJ, GRUNDY JE, GRIFFITHS PD (1986). AN IMPROVED RADIOIMMUNOASSAY METHOD FOR THE DETECTION OF IGG ANTIBODIES AGAINST CYTOMEGALOVIRUS. J VIROL METHODS, 13(4), 343 - 350.
    • GRUNDY JE, SUPER M, LUI SF, GRIFFITHS PD (1986). DONOR STRAINS OF CYTOMEGALOVIRUS IN RENAL-TRANSPLANT RECIPIENTS. NEW ENGL J MED, 315(19), 1229 - 1229.

    1985

    • GRIFFITHS PD (1985). RAPID DIAGNOSIS OF CYTOMEGALOVIRUS-INFECTION. J HOSP INFECT, 6, 35 - 41.
    • Rutter D, Griffiths P, Trompeter RS (1985). Cytomegalic inclusion disease after recurrent maternal infection. Lancet, 2(8465), 1182 - 1182.
    • McKeating JA, Stagno S, Stirk PR, Griffiths PD (1985). Detection of cytomegalovirus in urine samples by enzyme-linked immunosorbent assay. Journal of Medical Virology, 16(4), 367 - 373. doi:10.1002/jmv.1890160410
    • Du Bois R, Griffiths PD, Prentice HG (1985). Rapid diagnosis of cytomegalovirus infection. Lancet, 1(8421), 171 - 171.
    • McKeating JA, Al-Nakib W, Greenaway PJ, Griffiths PD (1985). Detection of cytomegalovirus by DNA-DNA hybridization employing probes labelled with 32-phosphorus or biotin. Journal of Virological Methods, 11(3), 297 - 216.

    1984

    • GRIFFITHS PD (1984). CYTOMEGALOVIRUS AND THE LIVER. SEMIN LIVER DIS, 4(4), 307 - 313.
    • GRIFFITHS PD, KANGRO HO (1984). A USERS GUIDE TO THE INDIRECT SOLID-PHASE RADIOIMMUNOASSAY FOR THE DETECTION OF CYTOMEGALOVIRUS-SPECIFIC IGM ANTIBODIES. J VIROL METHODS, 8(4), 271 - 282.
    • GRIFFITHS PD (1984). DIAGNOSTIC-TECHNIQUES FOR CYTOMEGALOVIRUS-INFECTION. CLIN HAEMATOL, 13(3), 631 - 644.
    • GRIFFITHS PD, STIRK PR, GANCZAKOWSKI M, PANJWANI DD, BALL MG, BLACKLOCK HA, PRENTICE HG (1984). RAPID DIAGNOSIS OF CYTOMEGALOVIRUS-INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCI. LANCET, 2(8414), 1242 - 1245.

    1983

    • GRIFFITHS PD (1983). SPECIFICITY AND SENSITIVITY OF A RADIOIMMUNOASSAY FOR SPECIFIC IGM ANTIBODIES TO CYTOMEGALOVIRUS. J INFECT DIS, 148(3), 616 - 617.

    • Kadambari S, Luck S, Davis A, Williams EJ, Berrington J, Griffiths PD, Sharland M (). Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme. Acta Paediatrica, , n/a - n/a. doi:10.1111/apa.12335
    • Barker KR, Sarafino-Wani R, Khanom A, Griffiths PD, Jacobs MG, Webster DP (). Encephalitis in an immunocompetent man. Journal of Clinical Virology, , - . doi:10.1016/j.jcv.2013.05.014
    • Griffiths PD (). Editorial: an anniversary and a new member of the family. Reviews in Medical Virology, 23(4), 211 - 212. doi:10.1002/rmv.1748